Toxoplasma gondii: Protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1

Experimental Parasitology

Volumn 128, Issue 1, 2011, Pages 38-43

  Yan, Hai Kuo ^a,b   Yuan, Zi Guo ^a,b   Petersen, Eskild ^c   Zhang, Xiu Xiang ^a   Zhou, Dong Hui ^a   Liu, Quan ^d   He, Yong ^a   Lin, Rui Qing ^a   Xu, Min Jun ^b   Chen, Xu Li ^a   Zhong, Xiu Ling ^a   Zhu, Xing Quan ^b,e  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c AARHUS UNIVERSITY   (Denmark)

^d AMMS   (China)

^e YUNNAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

DNA vaccine; Immunity; Mice; Perforin like protein 1 (PLP1); Toxoplasma gondii; Toxoplasmosis

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; GENOMIC DNA; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; PERFORIN; PERFORIN LIKE PROTEIN 1; PLASMID DNA; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DNA IMMUNIZATION; EXPERIMENTAL INFECTION; EXPRESSION VECTOR; FEMALE; GENE SEQUENCE; GENETIC CODE; GENETIC STRAIN; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MONOTHERAPY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE VIRULENCE; PLASMID; PRIORITY JOURNAL; PROVOCATION TEST; SURVIVAL TIME; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; PERFORIN; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TRANSFECTION; VACCINES, DNA;

ANIMALIA; EUKARYOTA; MUS; TOXOPLASMA GONDII;

EID: 79952900178     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2011.02.005     Document Type: Article

References (43)

1. Alarcon J.B., Waine G.W., McManus D.P. DNA vaccines: technology and application as antiparasite and anti-microbial agents. Advances in Parasitology 1999, 42:343-410.
2. Aldridge J.R., Johnson E.C., Kuhn R.E. CpG stimulates protective immunity in Balb/c mice infected with larval Taenia crassiceps. The Journal of Parasitology 2010, 96:920-928.
3. Bhopale G.M. Development of a vaccine for toxoplasmosis: current status. Microbes and Infection 2003, 5:457-462.
4. Bunelland B.A., Morgan R.A. Gene therapy for infectious diseases. Clinical Microbiology Reviews 1998, 11:42-56.
5. Dubey J.P., Hill D.E., Jones J.L., Hightower A.W., Kirkland E., Roberts J.M., Marcet P.L., Lehmann T., Vianna M.C., Miska K., Sreekumar C., Kwok O.C., Shen S.K., Gamble H.R. Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers. The Journal of Parasitology 2005, 91:1082-1093.
6. Fehniger T.A., Shah M.H., Turner M.J., VanDeusen J.B., Whitman S.P., Cooper M.A., Suzuki K., Wechser M., Goodsaid F., Caligiuri M.A. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. Journal of Immunology 1999, 162:4511-4520.
7. Gu Y., Kuida K., Tsutsui H., Ku G., Hsiao K., Fleming M.A., Hayashi N., Higashino K., Okamura H., Nakanishi K., Kurimoto M., Tanimoto T., Flavell R.A., Sato V., Harding M.W., Livingston D.J., Su M.S. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997, 275:206-209.
8. Gurunathan S., Wu C.Y., Freidag B.L., Seder R.A. DNA vaccines: a key for inducing long-term cellular immunity. Current Opinion in Immunology 2000, 12:442-447.
9. Hadders M.A., Beringer D.X., Gros P. Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense. Science 2007, 317:1552-1554.
10. Hyodo Y., Matsui K., Hayashi N., Tsutsui H., Kashiwamura S., Yamauchi H., Hiroishi K., Takeda K., Tagawa Y., Iwakura Y., Kayagaki N., Kurimoto M., Okamura H., Hada T., Yagita H., Akira S., Nakanishi K., Higashino K. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. Journal of Immunology 1999, 162:1662-1668.
11. Innes E.A., Vermeulen A.N. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology 2006, 133(Suppl):145-168.
12. Israelski D.M., Remington J.S. Toxoplasmosis in patients with cancer. Clinical Infectious Diseases 1993, 17(Suppl. 2):423-435.
13. Kafsack B.F., Pena J.D., Coppens I., Ravindran S., Boothroyd J.C., Carruthers V.B. Rapid membrane disruption by a perforin-like protein facilitates parasite exit from host cells. Science 2009, 323:530-533.
14. Kaiser K., Camargo N., Coppens I., Morrisey J.M., Vaidya A.B., Kappe S.H. A member of a conserved Plasmodium protein family with membrane-attack complex/perforin (MACPF)-like domains localizes to the micronemes of sporozoites. Molecular and Biochemical Parasitology 2004, 133:15-26.
15. Kim K., Weiss L.M. Toxoplasma gondii: the model apicomplexan. International Journal for Parasitology 2004, 34:423-432.
16. Kur J., Holec-Gasior L., Hiszczyńska-Sawicka E. Current status of toxoplasmosis vaccine development. Expert Review of Vaccines 2009, 8:791-808.
17. Letscher-Bru V., Villard O., Risse B., Zauke M., Klein J.P., Kien T.T. Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice. Infection and Immunity 1998, 66:4503-4506.
18. Liu M.M., Yuan Z.G., Peng G.H., Zhou D.H., He X.H., Yan C., Yin C.C., He Y., Lin R.Q., Song H.Q., Zhu X.Q. Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitology Research 2010, 106:1079-1084.
19. Luft B.J., Remington J.S. Toxoplasmic encephalitis in AIDS. Clinical Infectious Diseases 1992, 15:211-222.
20. Machado C.M., Boas L.S., Canto C.L., Andrade Júnior H.F., Castelli J., Bohringer P., Ostronoff M., Dulley F., Pannuti C.S. Disseminated toxoplasmosis after BMT-report of a case. Bone Marrow Transplantation 1992, 10:475-478.
21. Mastroeni P., Clare S., Khan S., Harrison J.A., Hormaeche C.E., Okamura H., Kurimoto M., Dougan G. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infection and Immunity 1999, 67:478-483.
22. Mishima M., Xuan X., Yokoyama N., Igarashi I., Fujisaki K., Nagasawa H., Mikami T. Recombinant feline herpesvirus type 1 expressing Toxoplasma gondi ROP2 antigen inducible protective immunity in cats. Parasitology Research 2002, 88:144-149.
23. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965-1976.
24. Mölder T., Adojaan M., Kaldma K., Ustav M., Sikut R. Elicitation of broad CTL response against HIV-1 by the DNA vaccine encoding artificial multi-component fusion protein MultiHIV-study in domestic pigs. Vaccine 2009, 28:293-298.
25. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., Kurimoto M. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378:88-91.
26. Okamura H., Nagata K., Komatsu T., Tanimoto T., Nukata Y., Tanabe F., Akita K., Torigoe K., Okura T., Fukuda S., Kurimoto M. A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infection and Immunity 1995, 63:3966-3972.
27. Peng G.H., Yuan Z.G., Zhou D.H., He X.H., Liu M.M., Yan C., Yin C.C., He Y., Lin R.Q., Zhu X.Q. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice. Vaccine 2009, 27:6570-6574.
28. Persson E.K., Agnarson A.M., Lambert H., Hitziger N., Yagita H., Chambers B.J., Barragan A., Grandien A. Death receptor ligation or exposure to perforin trigger rapid egress of the intracellular parasite Toxoplasma gondii. Journal of Immunology 2007, 179:8357-8365.
29. Persson C.M., Lambert H., Vutova P.P., Dellacasa-Lindberg I., Nederby J., Yagita H., Ljunggren H.G., Grandien A., Barragan A., Chambers B.J. Transmission of Toxoplasma gondii from infected dendritic cells to natural killer cells. Infection and Immunity 2009, 77:970-976.
30. Rosado C.J., Buckle A.M., Law R.H., Butcher R.E., Kan W.T., Bird C.H., Ung K., Browne K.A., Baran K., Bashtannyk-Puhalovich T.A., Faux N.G., Wong W., Porter C.J., Pike R.N., Ellisdon A.M., Pearce M.C., Bottomley S.P., Emsley J., Smith A.I., Rossjohn J., Hartland E.L., Voskoboinik I., Trapani J.A., Bird P.I., Dunstone M.A., Whisstock J.C. A common fold mediates vertebrate defense and bacterial attack. Science 2007, 317:1548-1551.
31. Rosado C.J., Kondos S., Bull T.E., Kuiper M.J., Law R.H., Buckle A.M., Voskoboinik I., Bird P.I., Trapani J.A., Whisstock J.C., Dunstone M.A. The MACPF/CDC family of pore-forming toxins. Cellular Microbiology 2008, 10:1765-1774.
32. Stone G.W., Barzee V., Snarsky V., Kee K., Spina C.A., Yu X.F., Kornbluth R.S. Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines. Journal of Virology 2006, 80:1762-1772.
33. Tweten R.K. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infection and Immunity 2005, 73:6199-6209.
34. Vercammen M., Scorza T., Huygen K., De Braekeleer J., Diet R., Jacobs D., Saman E., Verschueren H. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infection and Immunity 2000, 68:38-45.
35. Voskoboinik I., Smyth M.J., Trapani J.A. Perforin-mediated target-cell death and immune homeostasis. Nature Reviews. Immunology 2006, 6:940-952.
36. Wang X., Kang H., Kikuchi T., Suzuki Y. Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease. Infection and Immunity 2004, 72:4432-4438.
37. Wang H., Liu Q., Liu K., Zhong W., Gao S., Jiang L., An N. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitology International 2007, 56:263-268.
38. Wei X.Q., Leung B.P., Niedbala W., Piedrafita D., Feng G.J., Sweet M., Dobbie L., Smith A.J., Liew F.Y. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. Journal of Immunology 1999, 163:2821-2828.
39. Wei F., Liu Q., Gao S., Shang L., Zhai Y., Men J., Jiang L., Zhu X.Q., Fu Z., Shi Y., Xia Z., Lin J. Enhancement by IL-18 of the protective effect of a Schistosoma japonicum 26kDa GST plasmid DNA vaccine in mice. Vaccine 2008, 26:4145-4149.
40. Yuan Z.G., Zhang X.X., He X.H., Petersen E., Zhou D.H., He Y., Lin R.Q., Li X.Z., Chen X.L., Shi X.R., Zhong X.L., Zhang B., Zhu X.Q. Protective immunity induced by Toxoplasma gondii rhoptry protein 16 (ROP16) against toxoplasmosis in mice. Clinical and Vaccine Immunology 2011, 18:119-124.
41. Zhang T., Kawakami K., Qureshi M.H., Okamura H., Kurimoto M., Saito A. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infection and Immunity 1997, 65:3594-3599.
42. Zou F.C., Sun X.T., Xie Y.J., Li B., Zhao G.H., Duan G., Zhu X.Q. Seroprevalence of Toxoplasma gondii in pigs in Southwestern China. Parasitology International 2009, 58:306-307.
43. Zhang W., Dong S.F., Sun S.H., Wang Y., Li G.D., Qu D. Coimmunization with IL-15 plasmid enhances the longevity of CD8 T cells induced by DNA encoding hepatitis B virus core antigen. World Journal of Gastroenterology 2006, 12:4727-4735.